Literature DB >> 8048832

Liposomal amphotericin B in hepatic candidosis.

M Sharland1, R J Hay, E G Davies.   

Abstract

A 4 year old girl treated with a standard chemotherapy protocol for acute lymphoblastic leukaemia developed hepatic candidosis during the consolidation phase. This relapsed after a prolonged course of amphotericin B and flucytosine. An eight week course of liposomal amphotericin produced a marked clinical improvement which was sustained for one year. A subsequent relapse was associated with transformation to myelodysplastic leukaemia.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8048832      PMCID： PMC1029884          DOI： 10.1136/adc.70.6.546

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

Review 1.  Fungal infections in the pediatric cancer patient.

Authors:  P A Pizzo; T J Walsh
Journal:  Semin Oncol       Date:  1990-06       Impact factor: 4.929

2.  Conventional vs. liposomal amphotericin B in immunosuppressed children.

Authors:  A Zoubek; W Emminger; W Emminger-Schmidmeier; C Peters; E Pracher; N Grois; H Gadner
Journal:  Pediatr Hematol Oncol       Date:  1992 Apr-Jun       Impact factor: 1.969

3.  Hepatic candidiasis: an increasing problem in immunocompromised patients.

Authors:  E Haron; R Feld; P Tuffnell; B Patterson; R Hasselback; A Matlow
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

4.  Hepatosplenic candidiasis in children with acute leukemia.

Authors:  A Verdeguer; J M Fernández; C Esquembre; J Ferris; J G Ruiz; V Castel
Journal:  Cancer       Date:  1990-02-15       Impact factor: 6.860
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.